Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Cited by (1,066)

Items 201–300 of 1,066

1. Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma
   Laura A. Johnson, John Scholler, Takayuki Ohkuri, Akemi Kosaka, Prachi R. Patel, Shannon E. McGettigan, Arben Nace, Tzvete Dentchev, Pramod U. Thekkat, Andreas Loew et al. · 2015 · Science Translational Medicine
2. Loss of the Mismatch Repair Protein MSH6 in Human Glioblastomas Is Associated with Tumor Progression during Temozolomide Treatment
   Daniel P. Cahill, Kymberly K. Levine, Rebecca A. Betensky, Patrick J. Codd, Candice A. Romany, Linsey B. Reavie, Tracy T. Batchelor, P. Andrew Futreal, Michael R. Stratton, William T. Curry et al. · 2007 · Clinical Cancer Research
3. Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy
   Robert Michael Prins, Horacio Soto, Vera Konkankit, Sylvia K. Odesa, Ascia Eskin, William H. Yong, Stanley F. Nelson, Linda M. Liau · 2010 · Clinical Cancer Research
4. Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway
   Howard A. Burris · 2013 · Cancer Chemotherapy and Pharmacology
5. Clinical Applications of PET in Brain Tumors
   William C. Chen · 2007 · Journal of Nuclear Medicine
6. Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States
   Stuart A. Grossman, Xiaobu Ye, Steven Piantadosi, Serena Desideri, Burt Nabors, Myrna R. Rosenfeld, Joy D. Fisher · 2010 · Clinical Cancer Research
7. O2⋅− and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate
   Schoenfeld, Joshua D., Sibenaller, Zita A., Mapuskar, Kranti A., Wagner, Brett A., Cramer-Morales, Kimberly L., Furqan, Muhammad, Sandhu, Sonia, Carlisle, Thomas L., Smith, Mark C., Abu Hejleh, Taher et al. · 2017 · Cancer Cell
8. Glioblastoma targeted therapy: updated approaches from recent biological insights
   Mehdi Touat, Ahmed Idbaïh, Marc Sanson, Keith Lloyd Ligon · 2017 · Annals of Oncology
9. ASSOCIATION OF SURGICALLY ACQUIRED MOTOR AND LANGUAGE DEFICITS ON OVERALL SURVIVAL AFTER RESECTION OF GLIOBLASTOMA MULTIFORME
   Matthew J. McGirt, Debraj Raj Mukherjee, Kaisorn Lee Chaichana, Khoi D. Than, JON D. WEINGART, Alfredo Quiñones‐Hinojosa · 2009 · Neurosurgery
10. Primary brain tumours in adults
    Martin J. van den Bent, Marjolein Geurts, Pim J. French, Marion Smits, David Capper, Jacoline E. C. Bromberg, Susan Marina Chang · 2023 · The Lancet
11. Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study
    Bogdahn, U., Hau, P., Stockhammer, G., Venkataramana, N. K., Mahapatra, A. K., Suri, A., Balasubramaniam, A., Nair, S., Oliushine, V., Parfenov, V. et al. · 2011 · Neuro-Oncology
12. Evidence for Sequenced Molecular Evolution of IDH1 Mutant Glioblastoma From a Distinct Cell of Origin
    Albert Lai, Samir Kharbanda, Whitney B. Pope, Anh Nhat Tran, Orestes E. Solis, Franklin V. Peale Jr., William F. Forrest, Kanan Pujara, Jose Carrillo, Ajay Pandita et al. · 2011 · Journal of Clinical Oncology
13. MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma
    Andreana Laura Rivera, Christopher E. Pelloski, Mark R. Gilbert, Howard Colman, C. Cruz, Erik P. Sulman, Benjamin Nebiyou Bekele, Kenneth Aldape · 2009 · Neuro-Oncology
14. Impact of extent of resection for recurrent glioblastoma on overall survival
    Orin G. Bloch, Seunggu Jude Han, Soonmee Cha, Matthew Z. Sun, Manish Kumar Aghi, Michael W. McDermott, Mitchel Stuart Berger, Andrew T. Parsa · 2012 · Journal of neurosurgery
15. A Hypermutation Phenotype and Somatic MSH6 Mutations in Recurrent Human Malignant Gliomas after Alkylator Chemotherapy
    Chris Hunter, Raffaella Smith, Daniel P. Cahill, Philip Stephens, Claire Stevens, Jon W. Teague, Chris Greenman, Sarah Edkins, Graham R. Bignell, Helen Ruth Davies et al. · 2006 · Cancer Research
16. Proteomic and immunologic analyses of brain tumor exosomes
    Michael W. Graner, Óscar Álzate, Angelika M. Dechkovskaia, Jack D. Keene, John Howard Sampson, Duane A. Mitchell, Darell D. Bigner · 2008 · The FASEB Journal
17. Immune Microenvironment in Glioblastoma Subtypes
    Zhihong Chen, Dolores Hambardzumyan · 2018 · Frontiers in Immunology
18. A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study
    James M. Schuster, R. K. Lai, Lawrence David Recht, David A. Reardon, Nina A. Paleologos, Morris D. Groves, Maciej M. Mrugała, Randy L. Jensen, Joachim M. Baehring, Andrew Edward Sloan et al. · 2015 · Neuro-Oncology
19. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
    Hao Lin, Chaxian Liu, An-Kang Hu, Duanwu Zhang, Hui Yang, Ying Qing Mao · 2024 · Journal of Hematology & Oncology
20. Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group
    Philipp Karschnia, Jacob S. Young, Antonio Dono, Levin Häni, Tommaso Sciortino, Francesco Bruno, Stephanie T Juenger, Nico Teske, Ramin A. Morshed, Alexander F. Haddad et al. · 2022 · Neuro-Oncology
21. MicroRNA-451 Regulates LKB1/AMPK Signaling and Allows Adaptation to Metabolic Stress in Glioma Cells
    Jakub A. Godlewski, Michal Oskar Nowicki, Agnieszka Bronisz, Gerard James Nuovo, Jeff Palatini, Michael D. De Lay, James R. Van Brocklyn, Michael C. Ostrowski, Ennio Antonio Chiocca, Sean Edward Lawler · 2010 · Molecular Cell
22. MR Imaging Predictors of Molecular Profile and Survival: Multi-institutional Study of the TCGA Glioblastoma Data Set
    David A. Gutman, Lee Cooper, Scott N. Hwang, Chad A. Holder, Jingjing Gao, Tarun D. Aurora, William D. Dunn, Lisa M. Scarpace, Tom Mikkelsen, Rajan Jain et al. · 2013 · Radiology
23. Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy’s history, efficacy and application in humans
    Keon Mahmoudi, Alexandros Bouras, Dominique Bozec, Robert Ivkov, Costas G. Hadjipanayis · 2018 · International Journal of Hyperthermia
24. Epidemiology of Gliomas
    Quinn T. Ostrom, Haley R Gittleman, Lindsay C. Stetson, Selene M. Virk, Jill S. Barnholtz‐Sloan · 2014 · Cancer treatment and research
25. Clinical Experience with α-Particle–Emitting 211At: Treatment of Recurrent Brain Tumor Patients with 211At-Labeled Chimeric Antitenascin Monoclonal Antibody 81C6
    Michael R. Zalutsky, David A. Reardon, Gamal Akabani, R. Edward Coleman, Allan H. Friedman, Henry S. Friedman, Roger E. McLendon, Terence Z. Wong, Darell D. Bigner · 2007 · Journal of Nuclear Medicine
26. Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution
    Kim, Hoon, Zheng, Siyuan, Amini, Seyed S., Virk, Selene M., Mikkelsen, Tom, Brat, Daniel J., Grimsby, Jonna, Sougnez, Carrie, Muller, Florian, Hu, Jian et al. · 2015 · Genome Research
27. Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review
    Neha Chiruvolu Singh, Alexandra Miner, Lauren Hennis, Sandeep Mittal · 2020 · Cancer Drug Resistance
28. X-rays can trigger the FLASH effect: Ultra-high dose-rate synchrotron light source prevents normal brain injury after whole brain irradiation in mice
    Pierre Montay‐Gruel, Audrey Bouchet, Maud Jaccard, David Patin, Raphaël Serduc, Warren Aim, Kristoffer Petersson, Benoît Petit, Claude J. Bailat, Jean Bourhis et al. · 2018 · Radiotherapy and Oncology
29. RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas
    Zhaoshi Bao, Hui-Min Chen, Ming-Yu Yang, Chuan‐Bao Zhang, Kai Yu, Wan-Lu Ye, Bo-Qiang Hu, Wei Yan, Wei Zhang, Johnny C. Akers et al. · 2014 · Genome Research
30. DNA repair mechanisms in cancer development and therapy
    Alessandro Torgovnick, Björn Schumacher · 2015 · Frontiers in Genetics
31. MSH6 Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance
    Stephen S. F. Yip, Jiangyong Miao, Daniel P. Cahill, Anthony John Iafrate, Ken Aldape, Catherine L. Nutt, David N. Louis · 2009 · Clinical Cancer Research
32. Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma
    Maleeha A. Qazi, Parvez Vora, Chitra Venugopal, Sachdev S. Sidhu, Jason Moffat, Charles Swanton, Sheila Kumari Singh · 2017 · Annals of Oncology
33. Glioblastoma: clinical presentation, diagnosis, and management
    Chris McKinnon, Meera Nandhabalan, Scott A Murray, Puneet Plaha · 2021 · BMJ
34. Single-cell spatial immune landscapes of primary and metastatic brain tumours
    Elham Karimi, Miranda W. Yu, Sarah M. Maritan, Lucas J. M. Perus, Morteza Rezanejad, Mark Sorin, Matthew Dankner, Parvaneh Fallah, Samuel Doré, Dongmei Zuo et al. · 2023 · Nature
35. Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH
    John Gregory Cairncross, Meihua Wang, Robert Brian Jenkins, Edward G. Shaw, Caterina Giannini, David G Brachman, Jan C. Buckner, Karen Fink, Luís Souhami, Normand Laperrière et al. · 2014 · Journal of Clinical Oncology
36. Acidic stress promotes a glioma stem cell phenotype
    Anita B. Hjelmeland, Qiulian Wu, John M. Heddleston, Gaurav S. Choudhary, Jennifer MacSwords, Justin Durla Lathia, Roger E. McLendon, Daniel J. Lindner, Andrew Edward Sloan, Jeremy N. Rich · 2010 · Cell Death and Differentiation
37. Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre-and Post-tumor Resection for Recurrent GBM
    James M. Markert, Peter Liechty, Wenquan Wang, Shanna Gaston, Eunice Braz, Matthias Karrasch, Burt Nabors, Michael Anne Markiewicz, Alfred D. Lakeman, Cheryl Ann Palmer et al. · 2008 · Molecular Therapy
38. Endothelial Cells Create a Stem Cell Niche in Glioblastoma by Providing NOTCH Ligands That Nurture Self-Renewal of Cancer Stem-Like Cells
    Thant S. Zhu, Mark A. Costello, Caroline E. Talsma, Callie G. Flack, Jessica G. Crowley, Lisa L. Hamm, Xiaobing He, Shawn L. Hervey‐Jumper, Jason Heth, Karin M. Muraszko et al. · 2011 · Cancer Research
39. Regorafenib compared with lomustine in patients with relapsed glioblastoma (REGOMA): a multicentre, open-label, randomised, controlled, phase 2 trial
    Giuseppe Lombardi, Gian Luca De Salvo, Alba Ariela Brandes, Marica Eoli, Roberta Rudà, Marina Faedi, Ivan Roberto Lolli, Andrea Pace, Bruno Daniele, Francesco Pasqualetti et al. · 2018 · The Lancet Oncology
40. Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group
    Kenneth J. Cohen, Ian F. Pollack, T. Zhou, Allen B. Buxton, Emiko J. Holmes, P. C. Burger, Daniel Jay Brat, Marc K. Rosenblum, Ronald L. Hamilton, Robert S. Lavey et al. · 2011 · Neuro-Oncology
41. Federated learning enables big data for rare cancer boundary detection
    Pati, Sarthak, Baid, Ujjwal, Edwards, Brandon, Sheller, Micah, Wang, Shih-Han, Reina, G. Anthony, Foley, Patrick, Gruzdev, Alexey, Karkada, Deepthi, Davatzikos, Christos et al. · 2022 · Nature Communications
42. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients
    MARTIN J.B. TAPHOORN, Lily Claassens, Neil K. Aaronson, Corneel Coens, Murielle E.L. Mauer, David Osoba, Roger Stupp, R.O. Mirimanoff, Martin J. van den Bent, Andrew Bottomley · 2010 · European Journal of Cancer
43. Glioblastoma Stem Cells: Driving Resilience through Chaos
    Briana C. Prager, Shruti Bhargava, Vaidehi Mahadev, Christopher G. Hubert, Jeremy N. Rich · 2020 · Trends in cancer
44. Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy
    Xiaoyang Lan, David J. Jörg, Florence M.G. Cavalli, Laura M. Richards, Long V. Nguyen, Robert J. Vanner, Paul Guilhamon, Lilian Lee, Michelle M. Kushida, Davide Pellacani et al. · 2017 · Nature
45. Elevated cd3+ and cd8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level
    Kmiecik, Justyna, Poli, Aurélie, Brons, Nicolaas H.C., Waha, Andreas, Eide, Geir Egil, Enger, Per Øyvind, Zimmer, Jacques, Chekenya, Martha · 2013 · Journal of Neuroimmunology
46. ESTRO-ACROP guideline “target delineation of glioblastomas”
    Maximilian Niyazi, Michael Brada, Anthony J. Chalmers, Stephanie Elisabeth Combs, Sara Erridge, Alba Fiorentino, Anca‐Ligia Grosu, Frank J. Lagerwaard, Giuseppe Caracciolo Minniti, René‐Olivier Mirimanoff et al. · 2016 · Radiotherapy and Oncology
47. Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study
    Martin J. van den Bent, Brigitta G. Baumert, Sara Erridge, Michael A. Vogelbaum, Anna K. Nowak, Marc Sanson, Alba Ariela Brandes, Paul M. Clément, Jean Français Baurain, Warren P. Mason et al. · 2017 · The Lancet
48. Recurrent glioma clinical trial, CheckMate-143: the game is not over yet
    Anna C. Filley, Mario A. Henriquez, Mahua Dey · 2017 · Oncotarget
49. Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts
    Gaspar J. Kitange, Brett L. Carlson, Mark A. Schroeder, Patrick Thomas Grogan, Jeffrey D. Lamont, Paul A. Decker, Wenting Wu, Charles David James, Jann Nagina Sarkaria · 2008 · Neuro-Oncology
50. ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
    Congcong Zhang, Michael C. Burger, Lukas Jennewein, Sabrina Genßler, Kurt Schönfeld, Pia Susann Zeiner, Elke Hattingen, Patrick N. Harter, Michel Guy André Mittelbronn, Torsten Tonn et al. · 2015 · JNCI Journal of the National Cancer Institute
51. Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
    Surasak Phuphanich, Christopher J. Wheeler, Jeremy David Rudnick, Mia Mazer, Hongqian Wang, Miriam Nuño, Jaime Richardson, Xuemo Fan, Jianfei Ji, Ray M Chu et al. · 2012 · Cancer Immunology Immunotherapy
52. Molecular targets of glioma invasion
    Mitsutoshi Nakada, Satoko Nakada, Tim Demuth, Nhan L. Tran, Dominique B. Hoelzinger, Michael E. Berens · 2007 · Cellular and Molecular Life Sciences
53. Recurrence Pattern After Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed Patients With Glioblastoma: Correlation With MGMT Promoter Methylation Status
    Alba Ariela Brandes, Alicia Tosoni, Enrico Franceschi, Guido Sotti, Giampiero Frezza, Pietro Amistà, Luca Morandi, Federica Spagnolli, Mario Ermani · 2009 · Journal of Clinical Oncology
54. Prospects of immune checkpoint modulators in the treatment of glioblastoma
    Matthias Preusser, Michael K. Lim, David A. Hafler, David A. Reardon, John Howard Sampson · 2015 · Nature Reviews Neurology
55. A multigene predictor of outcome in glioblastoma
    Howard Colman, Lin Zhang, Erik P. Sulman, J. Matthew McDonald, N. L. Shooshtari, Andreana Laura Rivera, S. Popoff, Catherine L. Nutt, David N. Louis, John Gregory Cairncross et al. · 2009 · Neuro-Oncology
56. HER2-Specific T Cells Target Primary Glioblastoma Stem Cells and Induce Regression of Autologous Experimental Tumors
    Nabil M. Ahmed, Vita S. Salsman, Yvonne Kew, Donald R. Shaffer, Suzanne Zein-Eldin Powell, Yi J Zhang, Robert G. Grossman, Helen Elisabeth Heslop, Stephen M Gottschalk · 2010 · Clinical Cancer Research
57. Tumor-Treating Fields: A Fourth Modality in Cancer Treatment
    Mun, Elijah J., Babiker, Hani M., Weinberg, Uri, Kirson, Eilon D., Von Hoff, Daniel D. · 2018 · Clinical Cancer Research
58. O 6-Methylguanine DNA Methyltransferase Deficiency and Response to Temozolomide-Based Therapy in Patients with Neuroendocrine Tumors
    Matthew H. Kulke, Jason L. Hornick, Christine Frauenhoffer, Susanne M. Hooshmand, David P. Ryan, Peter C. Enzinger, Jeffrey A. Meyerhardt, Jeffrey William Clark, Keith E. Stuart, Charles S. Fuchs et al. · 2008 · Clinical Cancer Research
59. The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance
    Florian A. Siebzehnrübl, Daniel J. Silver, Buğra Tügertimur, Loic P. Deleyrolle, Dorit Siebzehnrubl, Matthew R. Sarkisian, Kelly G. Devers, Anthony T. Yachnis, Marius D. Kupper, Daniel Neal et al. · 2013 · EMBO Molecular Medicine
60. Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study
    James Perry, Karl Bélanger, Warren P. Mason, Dorcas S. Fulton, Petr Kavan, Jacob C. Easaw, Claude Shields, Sarah Kirby, David Macdonald, David D. Eisenstat et al. · 2010 · Journal of Clinical Oncology
61. Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma
    Stephanie L. Goff, Richard A. Morgan, James Chih-Hsin Yang, Richard Mark Sherry, Paul F. Robbins, Nicholas P. Restifo, Steven A. Feldman, Yong‐Chen Lu, Lily D. Lu, Zhili Zheng et al. · 2019 · Journal of Immunotherapy
62. Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
    Michael D. Prados, Susan Marina Chang, Nicholas Arthur Butowski, Rebecca Jane DeBoer, Rupa Parvataneni, Hannah Carliner, Paul Kabuubi, Jennifer R. Ayers-Ringler, Jane E. Rabbitt, Margaretta Page et al. · 2008 · Journal of Clinical Oncology
63. Towards the use of cannabinoids as antitumour agents
    Guillermo Velasco, Cristina Sánchez, Manuel Guzmán · 2012 · Nature reviews. Cancer
64. Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity
    Mona Meyer, Jüri Reimand, Xiaoyang Lan, Renee Head, Xueming Zhu, Michelle M. Kushida, Jane Bayani, Jessica C. Pressey, Anath Christopher Lionel, Ian D. Clarke et al. · 2015 · Proceedings of the National Academy of Sciences
65. Nanocarrier-based drug combination therapy for glioblastoma
    Mengnan Zhao, Demian van Straten, Marike L. D. Broekman, Véronique Préat A, Raymond Michel Schiffelers · 2020 · Theranostics
66. Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres
    Bar, Eli E., Lin, Alex, Mahairaki, Vasiliki, Matsui, William, Eberhart, Charles G. · 2010 · The American Journal of Pathology
67. Changing Paradigms—An Update on the Multidisciplinary Management of Malignant Glioma
    Roger Stupp, Monika E. Hegi, Martin J. van den Bent, Warren P. Mason, Michael Weller, R.O. Mirimanoff, John Gregory Cairncross · 2006 · The Oncologist
68. Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss
    Hideyuki Arita, Yoshitaka Narita, Shintaro Fukushima, Kensuke Tateishi, Yuko Matsushita, Akihiko Yoshida, Yasuji Miyakita, Makoto Ohno, Vincent Peter Collins, Nobutaka Kawahara et al. · 2013 · Acta Neuropathologica
69. Combinational Targeting Offsets Antigen Escape and Enhances Effector Functions of Adoptively Transferred T Cells in Glioblastoma
    Meenakshi G. Hegde, Amanda Corder, Kevin K. H. Chow, Malini Mukherjee, Aidin Ashoori, Yvonne Kew, Yi Jonathan Zhang, David S. Baskin, Fatima A. Merchant, Vita S. Brawley et al. · 2013 · Molecular Therapy
70. Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma
    Reshma A. Rangwala, Robert D. Leone, Yunyoung Claire Chang, Leslie Anne Fecher, Lynn Mara Schuchter, Amy Kramer, Kay-See Tan, Daniel F. Heitjan, Glenda Rodgers, Maryann Gallagher et al. · 2014 · Autophagy
71. Safety and Feasibility of Repeated and Transient Blood–Brain Barrier Disruption by Pulsed Ultrasound in Patients with Recurrent Glioblastoma
    Ahmed Idbaïh, Michael S. Canney, Lisa Belin, Carole Desseaux, Alexandre Vignot, Guillaume Bouchoux, Nicolas Asquier, Bruno Law-Ye, Delphine Leclercq, Anne Bissery et al. · 2019 · Clinical Cancer Research
72. Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma
    John Howard Sampson, Kenneth Aldape, Gerald E. Archer, April Coan, Annick Desjardins, Allan H. Friedman, Henry S. Friedman, Mark R. Gilbert, James E. Herndon, Roger E. McLendon et al. · 2010 · Neuro-Oncology
73. Immunotherapy for glioblastoma: current state, challenges, and future perspectives
    Yang Liu, Zhou Fei, Heba A. Ali, Justin Durla Lathia, Peiwen Chen · 2024 · Cellular and Molecular Immunology
74. Corticosteroids compromise survival in glioblastoma
    Kenneth L. Pitter, Ilaria Tamagno, Kristina Alikhanyan, Amira Hosni-Ahmed, Siobhan S. Pattwell, Shannon B. Donnola, Charles Sichao Dai, Tatsuya Ozawa, Maria Chang, Timothy An-thy Chan et al. · 2016 · Brain
75. Emerging treatment strategies for glioblastoma multiforme
    Steven K. Carlsson, Shaun P. Brothers, Claes Wahlestedt · 2014 · EMBO Molecular Medicine
76. Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
    Evanthia Galanis, Kurt A. Jaeckle, Matthew John Maurer, Joel M. Reid, Matthew M. Ames, James S. Hardwick, John F. Reilly, Andrey P. Loboda, Michael Nebozhyn, Valeria R. Fantin et al. · 2009 · Journal of Clinical Oncology
77. Oncogenic EGFR Signaling Networks in Glioma
    Paul H. Huang, Alexander M. Xu, Forest M. White · 2009 · Science Signaling
78. Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival
    Kloepper, Jonas, Riedemann, Lars, Amoozgar, Zohreh, Seano, Giorgio, Susek, Katharina, Yu, Veronica, Dalvie, Nisha, Amelung, Robin L., Datta, Meenal, Song, Jonathan W. et al. · 2016 · Proceedings of the National Academy of Sciences
79. Long Noncoding RNA NEAT1 , Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/ β -Catenin Pathway by Scaffolding EZH2
    Qun Chen, Jinquan Cai, Qixue Wang, Yunfei Wang, Mingyang Liu, Jingxuan Yang, Junhu Zhou, Chunsheng Kang, Min Li, Chuanlu Jiang · 2017 · Clinical Cancer Research
80. The time toxicity of cancer treatment
    Gupta, Arjun, Eisenhauer, Elizabeth A., Booth, Christopher M. · 2022 · Journal of Clinical Oncology
81. Scale to Predict Survival After Surgery for Recurrent Glioblastoma Multiforme
    John K. Park, Tiffany R. Hodges, Leopold Arko, Michael J. Shen, Donna M. DelloIacono, Adrian McNabb, Nancy Olsen Bailey, Teri Nguyen Kreisl, FABIO MASSAITI IWAMOTO, Joohee Sul et al. · 2010 · Journal of Clinical Oncology
82. A first-in-human phase 0 clinical study of RNA interference–based spherical nucleic acids in patients with recurrent glioblastoma
    Priya Kumthekar, Caroline H. Ko, Tatjana Paunesku, Karan Dixit, Adam M. Sonabend, Orin G. Bloch, Matthew C. Tate, Margaret A. Schwartz, Laura Zuckerman, Ray Lezon et al. · 2021 · Science Translational Medicine
83. A novel tumor suppressor protein encoded by circular AKT3 RNA inhibits glioblastoma tumorigenicity by competing with active phosphoinositide-dependent Kinase-1
    Xin Xia, Xixi Li, Fanying Li, Xujia Wu, Maolei Zhang, Huangkai Zhou, Nunu Huang, Xuesong Yang, Feizhe Xiao, Dawei Liu et al. · 2019 · Molecular Cancer
84. Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles
    Frank K.H. van Landeghem, K. Maier-Hauff, Andreas Jordan, Karl‐Titus Hoffmann, Uwe Gneveckow, R. Scholz, Burghard Thiesen, Wolfgang Brück, Andreas von Deimling · 2008 · Biomaterials
85. Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme
    Roberto Pallini M. D, Lucia Ricci‐Vitiani, Giuseppe Luigi Banna, Michele Signore, Dario Lombardi, Matilde Todaro, Giorgio Stassi, Maurizio Martini, Giulio Maira, Luigi Maria Larocca et al. · 2008 · Clinical Cancer Research
86. DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells
    M Katayama, T Kawaguchi, Mitchel Stuart Berger, Russell O. Pieper · 2006 · Cell Death and Differentiation
87. Multifunctional nanoparticles for brain tumor imaging and therapy
    Yu Cheng, Ramin A. Morshed, Brenda Auffinger, Alex L. Tobias, Maciej S. Lesniak · 2013 · Advanced Drug Delivery Reviews
88. EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy
    Guo, Deliang, Prins, Robert M., Dang, Julie, Kuga, Daisuke, Iwanami, Akio, Soto, Horacio, Lin, Kelly Y., Huang, Tiffany T., Akhavan, David, Hock, M. Benjamin et al. · 2009 · Science Signaling
89. Randomized Trial of Radiation Therapy Plus Procarbazine, Lomustine, and Vincristine Chemotherapy for Supratentorial Adult Low-Grade Glioma: Initial Results of RTOG 9802
    Edward G. Shaw, Meihua Wang, Stephen William Coons, David G Brachman, Jan C. Buckner, Keith J. Stelzer, Geoffrey R. Barger, Paul D. Brown, Mark R. Gilbert, Minesh P. Mehta · 2012 · Journal of Clinical Oncology
90. Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy
    Brenda Auffinger, Alex L. Tobias, Y Han, G Lee, D Guo, Mahua Dey, Maciej S. Lesniak, Atique U. Ahmed · 2014 · Cell Death and Differentiation
91. Tumour-infiltrating CD4+ and CD8+ lymphocytes as predictors of clinical outcome in glioma
    Sheng Han, C Zhang, Qingcong Li, Jinyun Dong, Y Liu, Yinde Huang, T Jiang, Anhua Wu · 2014 · British Journal of Cancer
92. High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Roger Stupp, Joerg‐Christian Tonn, Michael Brada, George E. Pentheroudakis · 2010 · Annals of Oncology
93. Mining TCGA database for genes of prognostic value in glioblastoma microenvironment
    Jia Di, Shenglan Li, Dali Li, Haipeng Xue, Dan Yang, Ying Liu · 2018 · Aging
94. MGMT Status as a Clinical Biomarker in Glioblastoma
    Madison K. Butler, Lőrinc Sándor Pongor, Yuting Su, Liqiang Xi, Mark A. Raffeld, Martha Quezado, Jane B. Trepel, Kenneth Aldape, Yves G. Pommier, Jing Wu · 2020 · Trends in cancer
95. Central Nervous System Tumors
    Jan C. Buckner, Paul D. Brown, Brian Patrick O’Neill, Fredric Bruce Meyer, Cynthia Wetmore, Joon H. Uhm · 2007 · Mayo Clinic Proceedings
96. A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool
    Lorea Manterola, Elizabeth Guruceaga, Jaime Gállego Pérez‐Larraya, Marisol González-Huarriz, Patricia Jáuregui, Sonia Tejada, Ricardo Díez-Valle, Víctor Segura, Nicolàs Samprón, Cristina Barrena et al. · 2014 · Neuro-Oncology
97. Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers
    Andrey Korshunov, Marina Vladimirovna Ryzhova, Volker Hovestadt, Sebastian Bender, Dominik Sturm, David Capper, Jochen Meyer, Daniel Schrimpf, Marcel Kool, Paul A. Northcott et al. · 2015 · Acta Neuropathologica
98. Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology
    K. R. Porter, Bridget J. McCarthy, Sally A. Freels, Young‐Woo Kim, Faye Davis · 2010 · Neuro-Oncology
99. Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data
    Wei Yang, Nicole M. Warrington, Sara J. Taylor, Paula Whitmire, Eduardo Carrasco, Kyle Singleton, Ningying Wu, Justin Durla Lathia, Michael E. Berens, Albert H. Kim et al. · 2019 · Science Translational Medicine
100. The landscape of the mesenchymal signature in brain tumours
     Jinan Behnan, Gaetano Finocchiaro, Gabi Hanna · 2019 · Brain